tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Shrader, 265 are a BUY (93.97%), 17 are a HOLD (6.03%).
Analyst Thomas Shrader, currently employed at BTIG, carries an average stock price target met ratio of 41.4% that have a potential upside of 46.68% achieved within 214 days.
Thomas Shrader’s has documented 536 price targets and ratings displayed on 58 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HROW, Harrow Health at 07-Oct-2026.
Analyst best performing recommendations are on NERV (MINERVA NEUROSCIENCES).
The best stock recommendation documented was for NERV (MINERVA NEUROSCIENCES) at 3/9/2023. The price target of $7 was fulfilled within 62 days with a profit of $5.19 (286.74%) receiving and performance score of 46.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-May-2021
$156
$89.61 (134.98%)
$157
12 days ago
(07-Oct-2026)
10/12 (83.33%)
$89.5 (134.59%)
443
Buy Since 13-Apr-2020
$120
$53.61 (80.75%)
$120
1 months 9 days ago
(10-Sep-2026)
35/43 (81.4%)
$47.5 (65.52%)
348
Buy Since 18-Feb-2020
$110
$43.61 (65.69%)
$96
1 months 18 days ago
(01-Sep-2026)
29/36 (80.56%)
$33.43 (43.66%)
524
Buy Since 22-Jul-2019
$111
$44.61 (67.19%)
$94
2 months 7 days ago
(12-Aug-2026)
18/20 (90%)
$27.16 (32.40%)
210
Buy Since 03-Jun-2026
$106
$39.61 (59.66%)
$104
2 months 7 days ago
(12-Aug-2026)
0/2 (0%)
$22.16 (26.43%)
Which stock is Thomas Shrader most bullish on?
Which stock is Thomas Shrader most reserved on?
What Year was the first public recommendation made by Thomas Shrader?
